Cite
HARVARD Citation
Gullo, G. et al. (n.d.). 1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10. European journal of cancer. pp. S321-. [Online].